Issuer Purchases of Equity Securities

Issuer Purchases of Equity Securities
Month Total Number of Shares Purchased(1) Average Price Paid per Share
October 1 through 31, 2015 409,885 $ 63.64
November 1 through 30, 2015 3,160,000 $ 66.29
December 1 through 31, 2015 1,582,297 $ 66.22
Total 5,152,182 $ 66.06
mber of SharesApproximate
Purchased asDollar
Part of
Value
Publicly
of Shares
Announced
That May
Plans
YetorbePrograms(2)
Purchased Under the Plans or Programs(3) (in millions)
347,300 3,990
3,160,000 3,780
1,524,377 3,679
5,031,677
Results of Operations
2015
Gross profit, GAAP $ 9,399
2012 Restructuring Program 20
Costs related to the sale of land in Mexico —
Gross profit, non-GAAP $ 9,419
2014 2013
$ 10,109 $ 10,201
29 32
4 15
$ 10,142 $ 10,248
2015 2014
Gross profit margin, GAAP 58.6% 58.5%
2012 Restructuring Program 0.10 0.20
Gross profit margin, non-GAAP 58.7% 58.7%
Basis Point Change 2013 Basis Point Change
10 58.6% (10)
0.20
— 58.8% (10)
2015
Selling, general and administrative expenses, GAAP $ 5,464
2012 Restructuring Program (64)
Selling, general and administrative expenses, non-GAAP $ 5,400
2014 2013
$ 5,982 $ 6,223
(62) (137)
$ 5,920 $ 6,086
Selling, general and administrative expenses as a percentage of Net sales, GAAP
2012 Restructuring Program
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP
2015 2014 Basis Point Change
34.1% 34.6% (50)
(0.40) (0.30)
33.7% 34.3% (60)
2013 Basis Point Change
35.7% (110)
(0.80)
34.9% (60)
Other (income) expense, net 2015
Amortization of intangible assets $ 33
Venezuela remeasurement charges 34
Gain on sale of South Pacific laundry detergent business (187)
Charges for foreign competition law matters 14
Equity (income) (8)
Other, net 6
Total Other (income) expense, net $ 62
2014 2013
$ 32 $ 32
195 202
327 172
— —
41 23
— 3
(7) (5)
(18) (5)
$ 570 $ 422
2015
Other (income) expense, net, GAAP $ 62
2012 Restructuring Program (170)
Venezuela remeasurement charges (34)
Gain on sale of South Pacific laundry detergent business 187
Charges for foreign competition law matters (14)
Other (income) expense, net, non-GAAP $ 31
2014 2013
$ 570 $ 422
(195) (202)
(327) (172)
— —
(41) (23)
— (3)
$ 7 $ 22
2015
Operating profit, GAAP $ 2,789
Venezuela accounting change 1,084
Operating profit, non-GAAP $ 3,988
2014 % Change 2013
$ 3,557 (22 )% $ 3,556
— —
286 371
327 172
— —
41 23
4 18
$ 4,215 (5 )% $ 4,140
% Change
—%
2%
2015
Operating profit margin, GAAP 17.4%
Venezuela accounting change 6.80
2012 Restructuring Program 1.60
Venezuela remeasurement charges 0.20
Gain on sale of South Pacific laundry detergent business (1.20)
Charges for foreign competition law matters 0.10
Operating profit margin, non-GAAP 24.9%
2014 Basis Point Change 2013
20.6% (320) 20.4%
— —
1.70 2.20
1.90 1.00
— —
0.20 0.10
— 0.10
24.4% 50 23.8%
Basis Point Change
20
60
2015
Effective income tax rate, GAAP 44.0%
Venezuela accounting change (1) (11.70)
2012 Restructuring Program (0.30)
Venezuela remeasurement charges —
Charges for foreign competition law matters (0.10)
Charges for foreign tax matters (0.40)
Effective income tax rate, non-GAAP 31.3%
2014 2013
33.8% 32.4%
— —
(0.50) (0.70)
0.10 0.20
— —
(0.30) (0.20)
(1.60) —
31.5% 31.7%
2015
Net income attributable to Colgate-Palmolive Company, GAAP $ 1,384
Venezuela accounting change 1,058
Charges for foreign tax matters 15
Net income attributable to Colgate-Palmolive Company, non-GAAP $ 2,556
2015 2014 % Change 2013
$ 2,180 (37 )% $ 2,241
— —
208 278
214 111
— —
41 23
3 12
66 —
$ 2,712 (6 )% $ 2,665
2013 % Change
(3 )%
2%
2015
Earnings per share, diluted, GAAP $ 1.52
Venezuela accounting change 1.16
2012 Restructuring Program 0.20
Venezuela remeasurement charges 0.02
Charges for foreign competition law matters 0.02
Charges for foreign tax matters 0.02
Earnings per share, diluted, non-GAAP $ 2.81
2014 % Change 2013
$ 2.36 (36 )% $ 2.38
— —
0.23 0.30
0.23 0.12
— —
0.04 0.03
— 0.01
0.07 —
$ 2.93 (4 )% $ 2.84
% Change
(1 )%
3%
North America
2015 2014
Net sales $ 3,149 $ 3,124
Operating profit $ 974 $ 926
% of Net sales 30.9% 29.6%
% Change 2013 % Change
1.00 % $ 3,072 1.50 %
5 % $ 927 — %
130 bps 30.2% (60) bps
Latin America
2015 2014
Net sales $ 4,327 $ 4,769
Operating profit $ 1,209 $ 1,279
% of Net sales 27.9% 26.8%
(9.50) % $ 5,012 (5.00) %
(5) % $ 1,385 (8) %
110 bps 27.6% (80) bps
Europe/South Pacific
2015 2014
Net sales $ 2,870 $ 3,406
% of Net sales 26.1% 25.7%
(15.50) % $ 3,396 0.50 %
(14) % $ 805 9 %
40 bps 23.7% 200 bps
Asia
2015 2014
Net sales $ 2,478 $ 2,515
% of Net sales 30.4% 29.3%
(1.50) % $ 2,472 1.50 %
2 % $ 698 5 %
110 bps 28.2% 110 bps
Africa/Eurasia
2015 2014
Net sales $ 998 $ 1,208
% of Net sales 17.8% 19.5%
(17.50) % $ 1,257 (4.00) %
(24) % $ 268 (12) %
(170) bps 21.3% (180) bps
Hill
2015 2014
Net sales $ 2,212 $ 2,255
% of Net sales 27.7% 26.3%
(2.00) % $ 2,211 2.00 %
3 % $ 563 5 %
140 bps 25.5% 80 bps
Corporate
2015 2014
Operating profit (loss) ($1,687) ($1,088)
55% ($1,090) — %
2015
2012 Restructuring Program ($254)
Charge for Venezuela accounting change (1,084)
Venezuela remeasurement charges (34)
Charges for foreign competition law matters (14)
Gain on sale of South Pacific laundry detergent business 187
Corporate overhead costs and other, net (488)
Total Corporate Operating profit (loss) ($1,687)
2014 2013
($286) ($371)
— —
(327) (172)
(41) (23)
(4) (18)
— —
(430) (506)
($1,088) ($1,090)
2015
Cost of sales $ 20
Selling, general and administrative expenses 64
Total 2012 Restructuring Program charges, pretax $ 254
Total 2012 Restructuring Program charges, aftertax $ 183

2014 2013
$ 29 $ 32
62 137
195 202
$ 286 $ 371
$ 208 $ 278
Program-to-date
2015 2014 2013 Accumulated Charges
North America 21% 11% 11% 13%
Latin America 3% 4% 4% 4%
Europe/South Pacific 15% 20% 28% 24%
Asia 3% 3% —% 2%
Africa/Eurasia 5% 3% 7% 5%
Hill’s Pet Nutrition 5% 10% 8% 7%
Corporate 48% 49% 42% 45%
Program-to-date
Accumulated Charges
Employee-RelatedCosts IncrementalDepreciation
Balance at January 1, 2013 $ 84 $—
Charges 144 26
Cash payments (97) —
Charges against assets (17) (26)
Foreign exchange 2 —
Other — —
Balance at December 31, 2013 $ 116 $—
Charges 73 25
Foreign exchange (4) —
Other — —
Charges 109 20
Other — —
mentalDepreciation AssetImpairments Other
$— $ 5
1 200
— (72)
(1) —
— —
— (91)
$— $ 42
1 187
— (117)
(1) —
— (5)
— —
$— $ 107
5 120
— (94)
(5) —
— (2)
— —
$— $ 131
Total
$ 89
371
(169)
(44)
2
(91)
$ 158
286
(212)
(31)
(9)
—
$ 192
254
(179)
(42)
(10)
—
$ 215
Non-GAAP Financial Measures
Organic
Sales Growth
Year ended December 31, 2015 (Non-GAAP) ForeignExchangeImpact
Oral, Personal and Home Care
North America 2.0% (1.0)%
Latin America 9.5% (19.0)%
Europe/South Pacific 1.0% (14.5)%
Asia 2.5% (4.5)%
Africa/Eurasia 6.0% (23.5)%
Total Oral, Personal and Home Care 4.5% (12.0)%
Pet Nutrition 6.0% (8.0)%
Total Company 5.0% (11.5)%
Acquisitions and DivestmentsImpact Net Sales Growth(GAAP)
—% 1.0%
—% (9.5)%
(2.0)% (15.5)%
0.5% (1.5)%
—% (17.5)%
(0.5)% (8.0)%
—% (2.0)%
(0.5)% (7.0)%
Year ended December 31, 2014 OrganicSales Growth(Non-GAAP) ForeignExchangeImpact
North America 2.5% (1.0)%
Latin America 9.0% (14.5)%
Europe/South Pacific 1.5% (0.5)%
Asia 4.5% (3.0)%
Africa/Eurasia 7.0% (11.0)%
Total Oral, Personal and Home Care 5.0% (6.0)%
Pet Nutrition 4.0% (2.0)%
Total Company 5.0% (6.0)%
Acquisitions and DivestmentsImpact Net Sales Growth(GAAP)
—% 1.5%
0.5% (5.0)%
(0.5)% 0.5%
—% 1.5%
—% (4.0)%
—% (1.0)%
—% 2.0%
—% (1.0)%
Cash Flow
2015
Weighted Average Interest Rate Maturities Outstanding
Payable to banks 1.8% 2016 $ 4
Commercial paper —% 2016 5
Total $ 9
2014
Outstanding Weighted Average Interest Rate Maturities Outstanding
1.9% 2015 $ 16
—% 2015 255
$ 271
Total
Long-term debt including current portion $ 6,567
Net cash interest payments on long-term debt(1) 1,376
Leases 926
Purchase obligations(2) 697
Total $ 9,566
2016 2017 2018
$ 298 $ 649 $ 698
129 110 108
188 152 139
449 125 83
$ 1,064 $ 1,036 $ 1,028
2018 2019 2020
$ 1,045 $ 248
102 100
129 120
16 16
$ 1,292 $ 484
Thereafter
$ 3,629
827
198
8
$ 4,662
Index to Financial Statements
Consolidated Financial Statements
Report of Independent Registered Public Accounting Firm
Consolidated Statements of Income for the years ended December 31, 2015, 2014 and 2013
Consolidated Statements of Comprehensive Income for the years ended December 31, 2015, 2014 and 2013
Consolidated Balance Sheets as of December 31, 2015 and 2014
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2015, 2014 and 2013
Consolidated Statements of Cash Flows for the years ended December 31, 2015, 2014 and 2013
Notes to Consolidated Financial Statements
Financial Statement Schedule
Schedule II - Valuation and Qualifying Accounts for the years ended December 31, 2015, 2014 and 2013
Selected Financial Data
Market and Dividend Information
Historical Financial Summary

Page
56
57
58
59
60
61
62
105
106
108
Consolidated Statements of Income
2015
Net sales $ 16,034
Cost of sales 6,635
Gross profit 9,399
Selling, general and administrative expenses 5,464
Charge for Venezuela accounting change 1,084
Operating profit 2,789
Interest (income) expense, net 26
Income before income taxes 2,763
Provision for income taxes 1,215
Net income including noncontrolling interests 1,548
Less: Net income attributable to noncontrolling interests 164
Net income attributable to Colgate-Palmolive Company $ 1,384
Earnings per common share, basic $ 1.53
Earnings per common share, diluted $ 1.52
2014 2013
$ 17,277 $ 17,420
7,168 7,219
10,109 10,201
5,982 6,223
570 422
— —
3,557 3,556
24 (9)
3,533 3,565
1,194 1,155
2,339 2,410
159 169
$ 2,180 $ 2,241
$ 2.38 $ 2.41
$ 2.36 $ 2.38
Consolidated Statements of Comprehensive Income
2015
Net income including noncontrolling interests $ 1,548
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments (645)
Retirement plan and other retiree benefit adjustments 196
Gains (losses) on available-for-sale securities (7)
Gains (losses) on cash flow hedges 2
Total Other comprehensive income (loss), net of tax (454)
Total Comprehensive income including noncontrolling interests 1,094
Less: Net income attributable to noncontrolling interests 164
Less: Cumulative translation adjustments attributable to noncontrolling interests (11)
Total Comprehensive income attributable to noncontrolling interests 153
Total Comprehensive income attributable to Colgate-Palmolive Company $ 941
2015 2014 2013
$ 1,548 $ 2,339 $ 2,410
(645) (685) (166)

196 (329) 318
(7) (48) 13
2 2 2
(454) (1,060) 167
1,094 1,279 2,577
164 159 169
(11) (4) (3)
153 155 166
$ 941 $ 1,124 $ 2,411
Consolidated Balance Sheets
Assets
Current Assets
Cash and cash equivalents
Receivables (net of allowances of $59 and $54, respectively)
Inventories
Other current assets
Total current assets
Property, plant and equipment, net
Goodwill
Other intangible assets, net
Deferred income taxes
Other assets
Total assets
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable
Current portion of long-term debt
Accounts payable
Accrued income taxes
Other accruals
Total current liabilities
Long-term debt
Other liabilities
Total liabilities
Commitments and contingent liabilities
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Unearned compensation
Treasury stock, at cost
Total Colgate-Palmolive Company shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities and equity
2015 2014
$ 970 $ 1,089
1,427 1,552
1,180 1,382
807 840
4,384 4,863
3,796 4,080
2,103 2,307
1,346 1,413
67 76
262 720
$ 11,958 $ 13,459
$ 4 $ 16
298 488
1,110 1,231
277 294
1,845 1,917
3,534 3,946
6,269 5,644
233 261
1,966 2,223
12,002 12,074
— —
1,466 1,466
1,438 1,236
18,861 18,832
(3,950) (3,507)
(12) (20)
(18,102) (16,862)
(299) 1,145
255 240
(44) 1,385
$ 11,958 $ 13,459
Consolidated Statements of Changes in Shareholders’ Equity
Common Stock Additional Paid-In Capi

Balance, January 1, 2013 $ 1,466 $ 818
Net income
Other comprehensive income (loss), net of tax
Dividends
Stock-based compensation expense 128
Shares issued for stock options 82
Shares issued for restricted stock awards (75)
Treasury stock acquired
Other 51
Balance, December 31, 2013 $ 1,466 $ 1,004
Net income
Dividends
Other 78
Net income
Dividends
Other 56
Colgate-Palmolive Company Shareholders’ Equity
Additional Paid-In Capital Unearned Compensation Treasury Stock
$ 818 ($41) ($14,386)
128
82 201
(75) 75
(1,521)
51 8 (2)
$ 1,004 ($33) ($15,633)
131
100 225
(77) 77
(1,530)
78 13 (1)
$ 1,236 ($20) ($16,862)
125
90 243
(69) 69
(1,551)
56 8 (1)
$ 1,438 ($12) ($18,102)
Retained Earnings Accumulated Other Comprehensive Income (Loss) Noncontrolling Interests
$ 16,953 ($2,621) $ 201
2,241 169
170 (3)
(1,242) (140)
4
$ 17,952 ($2,451) $ 231
2,180 159
(1,056) (4)
(1,300) (146)
$ 18,832 ($3,507) $ 240

1,384 164
(443) (11)
(1,355) (138)
$ 18,861 ($3,950) $ 255

Noncontrolling Interests
$ 201
169
(3)
(140)
4
$ 231
159
(4)
(146)
$ 240
164
(11)
(138)
$ 255
Consolidated Statements of Cash Flows
Operating Activities
Net income including noncontrolling interests
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization
Restructuring and termination benefits, net of cash
Venezuela remeasurement charges
Voluntary benefit plan contributions
Charge for a foreign tax matter
Stock-based compensation expense
Gain on sale of South Pacific laundry detergent business
Charge for Venezuela accounting change
Cash effects of changes in:
Receivables
Inventories
Accounts payable and other accruals
Other non-current assets and liabilities
Net cash provided by operations
Investing Activities
Capital expenditures
Sale of property and non-core product lines
Purchases of marketable securities and investments
Proceeds from sale of marketable securities and investments
Proceeds from sale of South Pacific laundry detergent business
Payment for acquisitions, net of cash acquired
Reduction in cash due to Venezuela accounting change
Other
Net cash used in investing activities
Financing Activities
Principal payments on debt
Proceeds from issuance of debt
Dividends paid
Purchases of treasury shares
Proceeds from exercise of stock options and excess tax benefits
Net cash used in financing activities
Effect of exchange rate changes on Cash and cash equivalents
Net (decrease) increase in Cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental Cash Flow Information
Income taxes paid
Interest paid
2015 2014 2013
$ 1,548 $ 2,339 $ 2,410
449 442 439

69 64 182
34 327 172
— (2) (101)
— 66 —
125 131 128
(187) — —
1,084 — —
(51) 18 71
(75) (109) (37)

(13) (60) (97)
(67) 57 24
33 25 13
2,949 3,298 3,204
(691) (757) (670)

9 24 15
(742) (340) (505)
599 283 267
221 — —
(13) (87) (3)
(75) — —
7 18 6
(685) (859) (890)
(9,181) (8,525) (7,554)

9,602 8,960 7,976
(1,493) (1,446) (1,382)
(1,551) (1,530) (1,521)
347 371 339
(2,276) (2,170) (2,142)
(107) (142) (94)
(119) 127 78
1,089 962 884
$ 970 $ 1,089 $ 962
$ 1,259 $ 1,009 $ 1,087
$ 131 $ 133 $ 118
2013
COLGATE-PALMOLIVE COMPANY
2015 2014 2013

Oral Care 47% 46% 46%
Personal Care 20% 21% 21%
Home Care 19% 20% 20%
Pet Nutrition 14% 13% 13%
Total 100% 100% 100%
2015
Cost of sales $ 20
Selling, general and administrative expenses 64
Total 2012 Restructuring Program charges, pretax $ 254
Total 2012 Restructuring Program charges, aftertax $ 183

2014 2013
$ 29 $ 32
62 137
195 202
$ 286 $ 371
$ 208 $ 278
Program-to-date
2015 2014 2013 Accumulated Charges
North America 21% 11% 11% 13%
Latin America 3% 4% 4% 4%
Europe/South Pacific 15% 20% 28% 24%
Asia 3% 3% —% 2%
Africa/Eurasia 5% 3% 7% 5%
Hill’s Pet Nutrition 5% 10% 8% 7%
Corporate 48% 49% 42% 45%
Program-to-date
Accumulated Charges
Employee-RelatedCosts IncrementalDepreciation
Balance at January 1, 2013 $ 84 $—
Charges 144 26
Foreign exchange 2 —
Other — —
Charges 73 25
Other — —
Charges 109 20
Other — —
mentalDepreciation AssetImpairments Other
$— $ 5
1 200
— (72)
(1) —
— —
— (91)
$— $ 42
1 187
— (117)
(1) —
— (5)
— —
$— $ 107
5 120
— (94)
(5) —
— (2)
— —
$— $ 131
Total
$ 89
371
(169)
(44)
2
(91)
$ 158
286
(212)
(31)
(9)
—
$ 192
254
(179)
(42)
(10)
—
$ 215
2015 2014
North America $ 333 $ 352
Latin America 224 320
Europe/South Pacific 1,307 1,374
Asia 149 160
Africa/Eurasia 75 86
Total Oral, Personal and Home Care 2,088 2,292
Pet Nutrition 15 15
Total Goodwill $ 2,103 $ 2,307
2014
$ 352
320
1,374
160
86
2,292
15
$ 2,307
2015
Gross Carrying Amount Accumulated Amortizatio
Trademarks $ 545 ($302)
Other finite life intangible assets 216 (64)
Indefinite life intangible assets 951 —
Total Other intangible assets $ 1,712 ($366)
2015
Accumulated Amortization Net Gross Carrying Amount
($302) $ 243 $ 552
(64) 152 213
— 951 987
($366) $ 1,346 $ 1,752
2014
Accumulated Amortization Net
($285) $ 267
(54) 159
— 987
($339) $ 1,413
Weighted Average Interest Rate

Notes 2.1% 2016
Commercial paper —%
Less: Current portion of long-term debt

Total
Maturities 2015 2014
2016 - 2,078 $ 6,562 $ 5,877
2016 5 255
6,567 6,132
298 488
$ 6,269 $ 5,644
Years Ended December 31,
2016 $ 298
2017 649
2018 698
2019 1,045
2020 248
Thereafter 3,629
Assets
Account Fair Value
Designated derivative instruments 12/31/15
Interest rate swap contracts Other current assets $—
Interest rate swap contracts Other assets 7
Foreign currency contracts Other current assets 131
Foreign currency contracts Other assets —
Commodity contracts Other current assets —
Total designated $ 138
Derivatives not designated

Foreign currency contracts Other assets 13
Total not designated $ 13
Total derivative instruments $ 151
Other financial instruments

Marketable securities Other current assets $ 61
Available-for-sale securities Other assets —
Note receivable Other current assets —
Total other financial instruments $ 61
ts Liabilities
Fair Value Account Fair Va
12/31/14 12/31/15
$ 1 Other accruals $—
12 Other liabilities —
21 Other accruals 5
— Other accruals —
$ 94 $ 5
$ 8 $—
$ 102 $ 5
$ 200
322
42
$ 564
Liabilities
Fair Value
12/31/15 12/31/14
$—
2
4
—
1
$ 7
—
$—
$ 7
2015
ForeignCurrencyContracts InterestRateSwaps
Notional Value at December 31, $ 573 $ 1,250
Gain (loss) on derivatives (3) (4)
Gain (loss) on hedged items 3 4
2014
Total ForeignCurrencyContracts InterestRateSwaps
$ 1,823 $ 1,163 $ 1,438
(7) 3 (8)
7 (3) 8
2014
InterestRateSwaps Total
$ 1,438 $ 2,601
(8) (5)
8 5
Cash Flow Hedges
2015
ForeignCurrencyContracts CommodityContracts
Notional Value at December 31, $ 745 $ 9
Gain (loss) recognized in OCI 19 (1)
Gain (loss) reclassified into Cost of sales 17 (1)
2015
CommodityContracts Total ForeignCurrencyContracts
$ 9 $ 754 $ 511
(1) 18 9
(1) 16 5
2014
CommodityContracts Total
$ 14 $ 525
— 9
— 5
2015
ForeignCurrencyContracts ForeignCurrencyDebt
Notional Value at December 31, $ 645 $ 800
Gain (loss) on instruments 73 48
Gain (loss) on hedged items (73) (48)
2014
Total ForeignCurrencyContracts ForeignCurrencyDebt
$ 1,445 $ 567 $ 297
121 73 11
(121) (73) (11)
2014
ForeignCurrencyDebt Total
$ 297 $ 864
11 84
(11) (84)
Derivatives Not Designated as Hedging Instruments
2015
Foreign Currency Contracts Cross-currencySwap
Notional Value at December 31, $— $ 102
Gain (loss) on instruments 7 4
Gain (loss) on hedged items — (4)
2014
Foreign Currency Contracts Cross-currencySwap
$— $ 102
— 5
— (5)
2015 2014
Beginning balance as of January 1 $ 399 $ 685
Unrealized gain (loss) on investment (17) (341)
Purchases and sales during the period 12 55
Venezuela accounting change (394) —
Ending balance as of December 31 $— $ 399
2014
Common Stock Outstanding

Balance, January 1, 2013 ###
Common stock acquired ###

Shares issued for stock options 7,883,834
Shares issued for restricted stock units and other 1,907,382
Balance, December 31, 2013 ###


Treasury Stock
###
25,573,317
(7,883,834)
(1,907,382)
###
23,131,081
(7,977,124)
(1,919,527)
###
22,802,784
(7,394,839)
(1,434,318)
###
2015 2014
Expected term of options 4.5 years 4.5 years
Expected volatility rate 17.6% 17.1%
Risk-free interest rate 1.5% 1.6%
Expected dividend yield 2.5% 2.3%
2013
4.5 years
18.4%
1.5%
2.3%
Shares(in thousands)
Restricted stock units as of January 1, 2015 3,694
Activity:
Granted 950
Vested (1,364)
Forfeited (114)
Restricted stock units as of December 31, 2015 3,166
Weighted Average Grant Date Fair Value Per Award
$ 56
66
51
59
$ 61
Stock Options
Shares(in thousands) Weighted Average Exercise Price

Options outstanding, January 1, 2015 42,902 $ 52
Granted 9,275 62
Exercised (7,826) 42
Forfeited or expired (431) 62
Options outstanding, December 31, 2015 43,920 56
Options exercisable, December 31, 2015 26,524 $ 52
Weighted Average Exercise Price Weighted Average Remaining Contractual Life(in years)
$ 52
62
42
62
56 4
$ 52 3
Intrinsic Value of Unexercised In-the-Money Options
$ 485
$ 402
Investments:
U.S. common stocks
International common stocks
Fixed income securities(a)
Common/collective trust funds(b):
Developed market equity index funds
Emerging market equity index funds
Other common stock funds
Fixed income funds: U.S. or foreign government and agency securities
Fixed income funds: investment grade corporate bonds
Fixed income funds: high yield corporate bonds and other
Guaranteed investment contracts(c)
Real estate funds(d)
Total Investments at fair value
Level of ValuationInput Pension Plans
United States International
Level 1 $ 16 $ 13
Level 1 126 3
Level 1 — —
Level 2 718 —
Level 2
321 185
28 8
123 23
25 102
113 68
114 47
Level 2 1 52
Level 3 39 19
$ 1,624 $ 520
Other RetireeBenefit Plans
$—
1
—
6
3
—
1
—
1
1
—
1
$ 14
Investments:
U.S. common stocks
International common stocks
Fixed income securities(a)
Common/collective trust funds(b):
Developed market equity index funds
Emerging market equity index funds
Other common stock funds
Fixed income funds: U.S. or foreign government and agency securities
Fixed income funds: investment grade corporate bonds
Fixed income funds: high yield corporate bonds and other
Guaranteed investment contracts(c)
Real estate funds(d)
Total Investments at fair value
Level of Valuation
Input Pension Plans
Level 1 $ 48 $ 10
Level 1 130 3
Level 1 — 2
Level 2 625 —
Level 2
352 193
32 8
118 27
115 107
168 75
136 54
Level 2 1 54
Level 3 46 19
$ 1,771 $ 552
Other RetireeBenefit Plans
$ 1
3
—
13
9
1
3
3
4
3
—
1
$ 41
2015
United States Real Estate Fund
Beginning balance as of January 1 $ 47
Earned income, net of management expenses 2
Unrealized gain (loss) on investment 5
Purchases, sales, issuances and settlements, net (14)
Ending balance as of December 31 $ 40
2015 2014
International Real Estate Fund United States Real Estate Fund International Real Estate Fun
$ 19 $ 41 $ 21
— 2 —
1 4 (1)
(1) — (1)
$ 19 $ 47 $ 19
International Real Estate Fund
$ 21
—
(1)
(1)
$ 19
2015
Change in Benefit Obligations

Benefit obligations at beginning of year $ 2,406
Service cost 2
Interest cost 100
Participants’ contributions —
Acquisitions/plan amendments —
Actuarial loss (gain) (189)
Foreign exchange impact —
Termination benefits (1) 16
Curtailments and settlements —
Benefit payments (134)
Other (2) —
Benefit obligations at end of year $ 2,201
Change in Plan Assets
Fair value of plan assets at beginning of year $ 1,771
Actual return on plan assets (33)
Company contributions 20
Participants’ contributions —
Foreign exchange impact —
Settlements —
Benefit payments (134)
Other —
Fair value of plan assets at end of year $ 1,624
Funded Status
Benefit obligations at end of year $ 2,201
Fair value of plan assets at end of year 1,624
Net amount recognized ($577)
Amounts Recognized in Balance Sheet
Noncurrent assets $—
Current liabilities (21)
Noncurrent liabilities (556)
Net amount recognized ($577)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss $ 852
Transition/prior service cost 2
$ 854
Accumulated benefit obligation $ 2,100
Pension Plans
2015 2014 2015
$ 2,406 $ 2,102 $ 916

2 1 20
100 102 28
— — 2
— — 3
(189) 362 (3)
— — (75)
16 5 —
— — (16)
(134) (154) (38)
— (12) (35)
$ 2,201 $ 2,406 $ 802
$ 1,771 $ 1,736 $ 552

(33) 178 20
20 23 35
— — 2
— — (35)
— — (14)
(134) (154) (38)
— (12) (2)
$ 1,624 $ 1,771 $ 520
$ 2,201 $ 2,406 $ 802

1,624 1,771 520
($577) ($635) ($282)
$— $— $ 17
(21) (20) (12)
(556) (615) (287)
($577) ($635) ($282)
$ 852 $ 933 $ 219

2 2 7
$ 854 $ 935 $ 226
$ 2,100 $ 2,283 $ 739
Other Retiree Benefit Plans
2014 2015 2014
International
$ 894 $ 1,011 $ 792

17 14 10
35 44 42
4 — —
— — —
123 (154) 203
(88) (14) (3)
— 1 —
(28) — —
(40) (40) (33)
(1) — —
$ 916 $ 862 $ 1,011
$ 558 $ 41 $ 41
65 — 4
36 13 29
4 — —
(43) — —
(27) — —
(40) (40) (33)
(1) — —
$ 552 $ 14 $ 41
$ 916 $ 862 $ 1,011

552 14 41
($364) ($848) ($970)
$ 6 $— $—
(28) (41) (41)
(342) (807) (929)
($364) ($848) ($970)
$ 259 $ 305 $ 481

19 (2) (3)
$ 278 $ 303 $ 478
$ 817 $— $—
efit Plans
2014
$ 792
10
42
—
—
203
(3)
—
—
(33)
—
$ 1,011
$ 41
4
29
—
—
—
(33)
—
$ 41
$ 1,011
41
($970)
$—
(41)
(929)
($970)
$ 481
(3)
$ 478
$—
2015
United States
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate 4.93%
Long-term rate of return on plan assets 6.80%
Long-term rate of compensation increase 3.50%
ESOP growth rate —%
Medical cost trend rate of increase —%
Pension Plans Other Retiree Bene
2014 2015 2014 2015
4.24% 3.17% 3.06% 4.97%

6.80% 4.62% 5.05% 6.80%
3.50% 2.78% 2.83% —%
—% —% —% 10.00%
—% —% —% 6.67%
2015 2014
4.36%
6.80%
—%
10.00%
7.00%
Years Ended December 31

2015
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation $ 2,667
Fair value of plan assets 1,792
Accumulated benefit obligation 2,499

Fair value of plan assets 1,772
Years Ended December 31,
2014
$ 2,958
1,955
2,725
1,922
2015
Components of Net Periodic Benefit Cost

Service cost $ 2
Interest cost 100
Annual ESOP allocation —
Expected return on plan assets (117)
Amortization of transition and prior service costs (credits) —
Amortization of actuarial loss 44
Net periodic benefit cost $ 29
Other postretirement charges 16
Total pension cost $ 45
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate 4.24%
Long-term rate of return on plan assets 6.80%
Long-term rate of compensation increase 3.50%
ESOP growth rate —%
Medical cost trend rate of increase —%
Pension Plans
2015 2014 2013
United States
$ 2 $ 1 $ 24
100 102 90
— — —
(117) (112) (118)
— 1 9
44 37 68
$ 29 $ 29 $ 73
16 5 102
$ 45 $ 34 $ 175
4.24% 4.96% 4.14%

6.80% 6.80% 7.30%
3.50% 3.50% 3.50%
—% —% —%
—% —% —%
Pension Plans
2015 2014 2013
International
$ 20 $ 17 $ 19
28 35 34
— — —
(28) (29) (26)
2 4 2
11 6 10
$ 33 $ 33 $ 39
(1) (8) 3
$ 32 $ 25 $ 42
3.06% 3.99% 3.57%

5.05% 5.50% 5.39%
2.83% 3.02% 2.80%
—% —% —%
—% —% —%
2013 2015 2014
$ 19 $ 14 $ 11
34 44 42
— — (1)
(26) (2) (3)
2 — 3
10 25 16
$ 39 $ 81 $ 68
3 1 —
$ 42 $ 82 $ 68
3.57% 4.36% 5.24%

5.39% 6.80% 6.80%
2.80% —% —%
—% 10.00% 10.00%
—% 7.00% 7.00%
efit Plans
2013
$ 13
38
(2)
(3)
1
21
$ 68
6
$ 74
4.32%
7.30%
—%
10.00%
7.50%
Expected Contributions and Benefit Payments
Pension Plans
Years Ended December 31, United States International
2016 $ 134 $ 40
2017 135 40
2018 136 35
2019 137 36
2020 150 38
2021-2025 730 215
nternational Other Retiree Benefit Plans Total
$ 42 $ 216
43 218
43 214
44 217
45 233
238 1,183
2015 2014
United States $ 1,118 $ 1,094
International 1,645 2,439
Total Income before income taxes $ 2,763 $ 3,533
2014 2013
$ 1,094 $ 1,018
2,439 2,547
$ 3,533 $ 3,565
2015 2014
United States $ 376 $ 348
International 839 846
Total Provision for income taxes $ 1,215 $ 1,194
2014 2013
$ 348 $ 314
846 841
$ 1,194 $ 1,155
2015 2014
Goodwill and intangible assets $ 3 ($40)
Property, plant and equipment (25) (13)
Pension and other retiree benefits 36 19
Stock-based compensation 11 11
Tax loss and tax credit carryforwards (4) 5
Other, net 98 (19)
Total deferred tax benefit (provision) $ 119 ($37)
2014 2013
($40) ($14)
(13) —
19 85
11 10
5 (30)
(19) (33)
($37) $ 18
Percentage of Income before income taxes 2015
Tax at United States statutory rate 35.0%
State income taxes, net of federal benefit 1.00
Earnings taxed at other than United States statutory rate (3.60)
Charge for a foreign tax matter (1) 0.50
Venezuela accounting change (2) 12.80
Other, net (1.70)
Effective tax rate 44.0%
2014 2013
35.0% 35.0%
0.70 0.40
(2.30) (1.40)
1.90 —
— —
(1.50) (1.60)
33.8% 32.4%
2015 2014
Deferred tax liabilities:
Goodwill and intangible assets ($458) ($497)
Property, plant and equipment (380) (380)
Other (150) (266)
(988) (1,143)
Deferred tax assets:
Pension and other retiree benefits 541 638
Tax loss and tax credit carryforwards 30 33
Accrued liabilities 235 276
Stock-based compensation 123 119
Other 151 148
1,080 1,214
Net deferred income taxes $ 92 $ 71
2014
($497)
(380)
(266)
(1,143)
638
33
276
119
148
1,214
$ 71
2015 2014
Deferred taxes included within:
Assets:
Other current assets $ 258 $ 256
Deferred income taxes 67 76
Liabilities:
Deferred income taxes (233) (261)
Net deferred income taxes $ 92 $ 71
2014
$ 256
76
(261)
$ 71
Unrecognized tax benefits:

Balance, January 1
Increases as a result of tax positions taken during the current year
Decreases of tax positions taken during prior years
Increases of tax positions taken during prior years
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations
Effect of foreign currency rate movements
Balance, December 31
2015 2014 2013
$ 218 $ 199 $ 212

20 23 23
(25) (11) (52)
61 32 37
(79) (10) (22)
(9) (15) 1
$ 186 $ 218 $ 199
2013
$ 212
23
(52)
37
(22)
1
$ 199
12. Earnings Per Share
For the Year Ended 2015

Net income attributable to Colgate-Palmolive Company Shares(millions)
Basic EPS $ 1,384 902.20
Stock options and restricted stock units 7.50
Diluted EPS $ 1,384 909.70
or the Year Ended 2015 For the Year Ended
Shares(millions) PerShare Net income attributable to Colgate-Palmolive Company
$ 1.53 $ 2,180
$ 1.52 $ 2,180
For the Year Ended 2014 For th
Shares(millions) PerShare Net income attributable to Colgate-Palmolive Company
915.10 $ 2.38 $ 2,241
9.20
924.30 $ 2.36 $ 2,241
For the Year Ended 2013
Shares(millions) PerShare
930.80 $ 2.41
9.10
939.90 $ 2.38
2015 2014
Net sales
North America(1) $ 3,149 $ 3,124
Latin America 4,327 4,769
Asia 2,478 2,515
Africa/Eurasia 998 1,208
Pet Nutrition(2) 2,212 2,255
Total Net sales $ 16,034 $ 17,277
2014 2013
$ 3,124 $ 3,072
4,769 5,012
3,406 3,396
2,515 2,472
1,208 1,257
15,022 15,209
2,255 2,211
$ 17,277 $ 17,420
2015 2014
Operating profit
Europe/South Pacific 750 877
Asia 753 736
Pet Nutrition 612 592
Corporate (1,687) (1,088)
Total Operating profit $ 2,789 $ 3,557
2014 2013
$ 926 $ 927
1,279 1,385
877 805
736 698
235 268
4,053 4,083
592 563
(1,088) (1,090)
$ 3,557 $ 3,556
2015 2014
Capital expenditures
Latin America 110 205
Asia 119 147
Total Oral, Personal and Home Care 490 580
Pet Nutrition 34 40
Corporate 167 137
Total Capital expenditures $ 691 $ 757
2014 2013
$ 136 $ 54
205 235
78 74
147 123
14 11
580 497
40 45
137 128
$ 757 $ 670
2015 2014
Depreciation and amortization
Latin America 88 93
Asia 94 78
Africa/Eurasia 8 10
Total Oral, Personal and Home Care 309 308
Pet Nutrition 52 52
Corporate 88 82
Total Depreciation and amortization $ 449 $ 442
2014 2013
$ 43 $ 51
93 93
84 85
78 72
10 11
308 312
52 51
82 76
$ 442 $ 439
2015 2014
Identifiable assets
North America $ 2,622 $ 2,326
Asia 1,882 1,903
Pet Nutrition 1,006 1,051
Corporate(1) 201 140
Total Identifiable assets(2) $ 11,958 $ 13,459
2014 2013
$ 2,326 $ 2,301
3,693 4,202
3,836 3,978
1,903 1,794
510 557
12,268 12,832
1,051 1,087
140 66
$ 13,459 $ 13,985
16. Supplemental Income Statement Information

Amortization of intangible assets $ 33
Equity (income) (8)
Other, net 6
Total Other (income) expense, net $ 62
2014 2013
$ 32 $ 32
195 202
327 172
— —
41 23
— 3
(7) (5)
(18) (5)
$ 570 $ 422
Interest (income) expense, net 2015 2014
Interest incurred $ 139 $ 134
Interest capitalized (6) (4)
Interest income (107) (106)
Total Interest (income) expense, net $ 26 $ 24
2014 2013
$ 134 $ 119
(4) (3)
(106) (125)
$ 24 ($9)
2015 2014
Research and development $ 274 $ 277
Advertising $ 1,491 $ 1,784
2014 2013
$ 267
$ 1,891
Inventories 2015 2014

Raw materials and supplies $ 261 $ 349
Work-in-process 45 55
Finished goods 874 978
Total Inventories $ 1,180 $ 1,382
2014
Property, plant and equipment, net 2015
Land $ 153
Buildings 1,492
Manufacturing machinery and equipment 5,166
Other equipment 1,248
8,059
Accumulated depreciation (4,263)
Total Property, plant and equipment, net $ 3,796
2014
$ 250
1,660
5,220
1,255
8,385
(4,305)
$ 4,080
Other accruals 2015
Accrued advertising and coupon redemption $ 512
Accrued payroll and employee benefits 322
Accrued taxes other than income taxes 121
Restructuring accrual 119
Pension and other retiree benefits 74
Accrued interest 36
Derivatives 5
Other 656
Total Other accruals $ 1,845
2014
$ 550
332
122
114
89
28
5
677
$ 1,917
Other liabilities 2015 2014
Pension and other retiree benefits $ 1,650 $ 1,886
Restructuring accrual 96 78
Other 220 259
Total Other liabilities $ 1,966 $ 2,223
2014
$ 1,886
78
259
$ 2,223
Cumulative translation adjustments

Reclassification due to Venezuela accounting change(1)
Cumulative translation adjustments
Pension and other benefits:
Net actuarial gain (loss) and prior service costs arising during the period
Amortization of net actuarial loss, transition and prior service costs(2)
Curtailment loss - unamortized prior service costs(2)
Retirement Plan and other retiree benefitadjustments
Available-for-sale securities:
Unrealized gains (losses) on available- for-sale securities(3)
Reclassification of (gains) losses into net earnings on available- for-sale securities(4)
Gains (losses) on available-for-sale securities
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges
Reclassification of (gains) losses into net earnings on cash flow hedges(5)
Gains (losses) on cash flow hedges
Total Other comprehensive income (loss)
2015 2014
Pre-tax Net of Tax Pre-tax
($721) ($745) ($663)

111 111 —
(610) (634) (663)
182 115 (580)

82 52 67
— — —
44 29 —
308 196 (513)
(18) (12) (341)

14 11 267
(10) (6) —
(14) (7) (74)
18 12 9
(16) (10) (5)
2 2 4
($314) ($443) ($1,246)
2014 2013
Pre-tax Net of Tax Pre-tax Net of Tax
($681) ($188) ($163)

— — —
(681) (188) (163)
(374) 295 189

45 111 70
— 91 59
— — —
(329) 497 318
(222) (113) (73)

174 133 86
— — —
(48) 20 13
6 20 13
(4) (17) (11)
2 3 2
($1,056) $ 332 $ 170
Net of Tax
Total
2015
Net sales $ 16,034
Gross profit 9,399
Net income (loss) including noncontrolling interests 1,548
Net income (loss) attributable to Colgate-Palmolive Company 1,384
Earnings (loss) per common share:
Basic 1.53
Diluted 1.52
2014
Net sales $ 17,277
Gross profit 10,109
Net income including noncontrolling interests 2,339
Net income attributable to Colgate-Palmolive Company 2,180
Earnings per common share:
Basic 2.38
Diluted 2.36
FirstQuarter SecondQuarter
$ 4,070 $ 4,066
(1) 2,392 (3) 2,367 (5)
(2) 583 (4) 616 (6)
(2) 542 (4) 574 (6)
(2) 0.60 (4) 0.63 (6)

(2) 0.59 (4) 0.63 (6)
$ 4,325 $ 4,352
(11) 2,524 (13) 2,552 (15)
(12) 432 (14) 661 (16)
(12) 388 (14) 622 (16)
(12) 0.42 (14) 0.68 (16)

(12) 0.42 (14) 0.67 (16)
ThirdQuarter FourthQuarter
$ 3,999 $ 3,899
2,347 (7) 2,293 (9)
770 (8) (421) (10)
726 (8) (458) (10)
0.81 (8) (0.51) (10)

0.80 (8) (0.51) (10) (21)
$ 4,379 $ 4,221
2,558 (17) 2,475 (19)
580 (18) 666 (20)
542 (18) 628 (20)
0.59 (18) 0.69 (20)

0.59 (18) 0.68 (20)
Market Price of Common Stock

2015
Quarter Ended High Low
March 31 $ 71.46 $ 65.12
June 30 70.08 65.34
September 30 69.08 60.37
December 31 69.23 63.72
Year-end Closing Price $ 66.62
2014
Low High Low
$ 65.08 $ 60.17
69.43 64.22
69.79 63.40
71.00 63.11
66.62 $ 69.19
Dividends Paid Per Common Share
Quarter Ended 2015 2014

March 31 $ 0.36 $ 0.34
June 30 0.38 0.36
September 30 0.38 0.36
December 31 0.38 0.36
Total $ 1.50 $ 1.42
2015
Continuing Operations
Net sales $ 16,034
Results of operations:
Net income attributable to Colgate-Palmolive Company 1,384
Per common share, basic 1.53
Per common share, diluted 1.52
Depreciation and amortization expense 449
Financial Position
Current ratio 1.20
Property, plant and equipment, net 3,796
Capital expenditures 691
Total assets 11,958
Long-term debt 6,269
Colgate-Palmolive Company shareholders’ equity (299)
Share and Other

Book value per common share (0.04)
Cash dividends declared and paid per common share 1.50
Closing price 66.62
Number of common shares outstanding (in millions) 892.70
Number of common shareholders of record 24,400
Number of employees 37,900
2014 2013
$ 17,277 $ 17,420
(1) 2,180 (2) 2,241 (3)

(1) 2.38 (2) 2.41 (3)
(1) 2.36 (2) 2.38 (3)
442 439
1.20 1.10
4,080 4,083
757 670
13,459 13,985
5,644 4,749
1,145 2,305
1.55 2.79
1.42 1.33
69.19 65.21
906.70 919.90
25,400 26,900
37,700 37,400
2012 2011 2010
$ 17,085 $ 16,734 $ 15,564
2,472 (4) 2,431 (5) 2,203

2.60 (4) 2.49 (5) 2.22
2.57 (4) 2.47 (5) 2.16
425 421 376
1.20 1.20 1.00

3,842 3,668 3,693
565 537 550
13,394 12,724 11,172
4,926 4,430 2,815
2,189 2,375 2,675
2.60 2.71 2.95

1.22 1.14 1.02
52.27 46.20 40.19
935.80 960.00 989.80
27,600 28,900 29,900
37,700 38,600 39,200
2010 2009 2008
$ 15,327 $ 15,330
(6) 2,291 1,957 (7)

(6) 2.26 1.91 (7)
(6) 2.18 1.83 (7)
351 348
1.10 1.30
3,516 3,119
575 684
11,134 9,979
2,821 3,585
3,116 1,923
3.26 2.04
0.86 0.78
41.08 34.27
988.40 1,002.80
30,600 31,400
38,100 36,600
2007 2006
$ 13,790 $ 12,238
1,737 (8) 1,353 (9)

1.67 (8) 1.29 (9)
1.60 (8) 1.23 (9)
334 329
1.10 1.00
3,015 2,696
583 476
10,112 9,138
3,222 2,720
2,286 1,411
2.37 1.51
0.70 0.63
38.98 32.62
1,018.00 1,025.40
32,200 33,400
36,000 34,700
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
2015
Earnings:
Income before income taxes $ 2,763
Add:
Fixed charges 216
Less:
Income from equity investees (8)
Capitalized interest (6)
Income as adjusted $ 2,965
Fixed Charges:
Interest on indebtedness and amortization of debt expense discount or premium $ 133
Portion of rents representative of interest factor 77
Capitalized interest 6
Total fixed charges $ 216
Ratio of earnings to fixed charges 13.70
2015 2014 2013
$ 2,763 $ 3,533 $ 3,565
216 212 196
(8) (7) (5)

(6) (4) (3)
$ 2,965 $ 3,734 $ 3,753
$ 133 $ 130 $ 116

77 78 77
6 4 3
$ 216 $ 212 $ 196
13.70 17.60 19.10
2012 2011
$ 3,874 $ 3,789
157 141
(7) (6)
(1) (1)
$ 4,023 $ 3,923
$ 80 $ 58
76 82
1 1
$ 157 $ 141
25.60 27.80
SUBSIDIARIES OF THE REGISTRANT
Name of Company
Colgate (Guangzhou) Company Limited
Colgate Flavors and Fragrances, Inc.
Colgate Holdings
Colgate Oral Pharmaceuticals, Inc.
Colgate-Palmolive (Middle East Exports) Ltd.
Colgate-Palmolive Europe Sarl
Colgate-Palmolive, Unipessoal, Lda.
Colgate-Palmolive Peru S.A.
Colgate Sanxiao Company Limited
Colgate-Palmolive S.p.A.
Colgate-Palmolive (America), Inc.
Colgate-Palmolive (Asia) Pte. Ltd.
Colgate-Palmolive (Caribbean) Inc.
Colgate-Palmolive (Central America), Inc.
Colgate-Palmolive (Dominican Republic), Inc.
Colgate-Palmolive (Eastern) Pte. Ltd.
Colgate-Palmolive (China) Co. Ltd.
Colgate-Palmolive (H.K.) Limited
Colgate-Palmolive (Hellas) S.A.I.C.
*Colgate-Palmolive (India) Limited
Colgate-Palmolive (Malaysia) Sdn Bhd
Colgate Palmolive (Marketing) Sdn Bhd
Colgate-Palmolive (Poland) SP. Zo.o.
Colgate-Palmolive (Proprietary) Limited
Colgate-Palmolive (Thailand) Limited
Colgate-Palmolive A/S
Colgate-Palmolive AB
Colgate-Palmolive Argentina S.A.
Colgate-Palmolive Belgium SA/NV
Colgate-Palmolive Canada Inc.
Colgate-Palmolive Ceska republika, s.r.o.
Colgate-Palmolive S.A.
Colgate-Palmolive Cia.
Colgate-Palmolive C.A.
Colgate-Palmolive Company, Distr.
Colgate-Palmolive de Puerto Rico, Inc.
Colgate-Palmolive del Ecuador Sociedad Anonima Industrial Y Comercial
Colgate-Palmolive España, S.A./N.V.
Colgate-Palmolive GmbH
Colgate-Palmolive Holding S. Com p.a.
Colgate-Palmolive Inc. S.A.
Colgate-Palmolive (Myanmar) Limited
Colgate-Palmolive Ghana Limited
CP West East Investment Limited
Colgate-Palmolive (Middle East Exports) Limited
Jurisdiction of Organization
China
Delaware
United Kingdom
Delaware
BVI
Switzerland
Portugal
Peru
China
Italy
Delaware
Singapore
Delaware
Delaware
Delaware
Singapore
China
Hong Kong
Greece
India
Malaysia
Malaysia
Poland
South Africa
Thailand
Denmark
Sweden
Argentina
Belgium
Canada
Czech Republic
Chile
Delaware
Venezuela
Puerto Rico
Delaware
Ecuador
Spain
Germany
Spain
Uruguay
Myanmar
Ghana
Nigeria
United Arab Emirates
EXHIBIT 21
Name of Company
Colgate-Palmolive Comercial Ltda.
Colgate-Palmolive International LLC
Colgate-Palmolive Lanka (Private) Limited
Colgate-Palmolive Limited
Colgate-Palmolive Manufacturing (Poland) SP. ZO.O
Colgate-Palmolive Moroc S.A.
Colgate-Palmolive Nederland BV
Colgate-Palmolive Norge AS
Colgate-Palmolive Operations (Ireland) Ltd.
Colgate-Palmolive Philippines, Inc.
Colgate-Palmolive Pty Limited
Colgate-Palmolive Senegal S.A.
Colgate-Palmolive Services (Belgium) S.A./N.V.
Colgate-Palmolive Services S.A.
Colgate-Palmolive Temizlik Urunleri Sanayi ve Ticaret Anonim Sirketi
Colgate-Palmolive (Vietnam) Limited
Colgate-Palmolive, S.A. de C.V.
Cotelle S.A.
CPIF Venture, Inc.
GABA Holding AG
*Hawley & Hazel Chemical (Taiwan) Corp. Ltd.
*Hawley & Hazel Chemical Company (Hong Kong) Limited
*Hawley & Hazel Chemical Company (Zhong Shan) Limited
Hill’s Pet Nutrition Asia-Pacific, Pte. Ltd.
Hill’s Pet Nutrition Indiana, Inc.
Hill’s Pet Nutrition Limited
Hill’s Pet Nutrition Manufacturing B.V.
Hill’s Pet Nutrition Manufacturing, s.r.o.
Hill’s Pet Nutrition Sales, Inc.
Hill’s Pet Nutrition S.N.C.
Hill’s Pet Nutrition, Inc.
Hill’s Pet Products, Inc.
Hill’s-Colgate (Japan) Ltd.
Inmobiliara Colpal, S. de R.L. de C.V.
Inmobiliara Hills, S.A. de C.V.
Mission Hills, S.A. de C.V.
Norwood International, Incorporated
Tom’s of Maine, Inc.
Jurisdiction of Organization
Brazil
Delaware
Sri Lanka
New Zealand
Poland
Morocco
Netherlands
Norway
Ireland
Philippines
Australia
Senegal
Belgium
France
Turkey
Vietnam
Mexico
France
Delaware
Switzerland
Taiwan
Hong Kong
China
Singapore
Delaware
United Kingdom
Netherlands
Czech Republic
Delaware
France
Delaware
Delaware
Japan
Mexico
Mexico
Mexico
Delaware
Maine
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
/s/ PricewaterhouseCoopers LLP

Colgate Palmolive CO
/s/ Ian Cook

Ian Cook
Chairman of the Board, President andChief Executive Officer
/s/ Dennis J. Hickey

Dennis J. Hickey
Chief Financial Officer
/s/ Ian Cook

Ian Cook
Chairman of the Board, President and Chief Executive Officer
/s/ Dennis J. Hickey

Dennis J. Hickey
Chief Financial Officer

Issuer Purchases of Equity Securities

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Issuer Purchases of Equity Securities

Uploaded by

Copyright:

Available Formats

Issuer Purchases of Equity Securities

Total 2012 Restructuring Program charges, aftertax $ 183

Consolidated Financial Statements

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2015 and 2014

Notes to Consolidated Financial Statements

Financial Statement Schedule

Selected Financial Data

Market and Dividend Information

Historical Financial Summary

(645) (685) (166)

Common Stock Additional Paid-In Capi

$ 18,832 ($3,507) $ 240

$ 18,861 ($3,950) $ 255

$ 1,548 $ 2,339 $ 2,410

449 442 439

(75) (109) (37)

(691) (757) (670)

(9,181) (8,525) (7,554)

2015 2014 2013

Total 2012 Restructuring Program charges, aftertax $ 183

Weighted Average Interest Rate

Less: Current portion of long-term debt

Derivatives not designated

Total derivative instruments $ 151

Other financial instruments

Common Stock Outstanding

Common stock acquired ###

Common stock acquired ###

Common stock acquired ###

Shares(in thousands) Weighted Average Exercise Price

Change in Benefit Obligations

$ 2,406 $ 2,102 $ 916

$ 1,771 $ 1,736 $ 552

$ 2,201 $ 2,406 $ 802

$ 852 $ 933 $ 219

$ 894 $ 1,011 $ 792

$ 916 $ 862 $ 1,011

$ 259 $ 305 $ 481

4.24% 3.17% 3.06% 4.97%

Years Ended December 31

Accumulated benefit obligation 2,499

Components of Net Periodic Benefit Cost

4.24% 4.96% 4.14%

3.06% 3.99% 3.57%

3.57% 4.36% 5.24%

Unrecognized tax benefits:

$ 218 $ 199 $ 212

For the Year Ended 2015

Other (income) expense, net 2015

Inventories 2015 2014

Cumulative translation adjustments

($721) ($745) ($663)

182 115 (580)

(18) (12) (341)

($681) ($188) ($163)

(374) 295 189

(222) (113) (73)

(2) 0.60 (4) 0.63 (6)

(12) 0.42 (14) 0.68 (16)

0.81 (8) (0.51) (10)

0.59 (18) 0.69 (20)

Market Price of Common Stock